Ozempic gets green light for diabetes in India, Mystery illness kills 14 kids in Nagpur, Chhindwara

In this segment of 5 Live, the focus is on the Indian drug regulator CDSCO's approval of the blockbuster drug Ozempic. It is cleared for treating type 2 diabetes and reducing risks of serious heart and kidney problems, but explicitly not for...

Act fast in heart attack emergencies: Subtle symptoms to recognise

Every year, thousands of Indians die from heart attacks not because treatment is unavailable, but because help is delayed. The "golden hour", which is the first 60 to 90 minutes after symptoms begin, is crucial. Acting quickly in that window can...

Pfizer Reaches Landmark Deal with Trump Administration to Lower Medicaid Drug Costs

By Emmanuel Ogbonna Pfizer has reached an agreement with the Trump administration to reduce the cost of prescription drugs for Medicaid patients, a move President Donald Trump hailed Tuesday as a breakthrough in his push to make medications more...

Trump hits pharmaceutical industry hard in latest round of tariffs

President Donald Trump addresses the federal appeals court ruling against his tariffs during a press conference. President Donald Trump announced his newest round of tariffs set to take effect on Oct. 1 in a series of Truth Social posts Thursday...

From shaving cuts to sun damage: Key health steps for men's skin

For years, skincare aisles have been split into "men’s" and "women’s" sections, with packaging, fragrances, and labels designed to appeal to one gender or the other. This marketing tactic has fueled the misconception that men need an entirely...

Indian diet contains 62% carbs, linked to rising diabetes, obesity: ICMR

A recent nationwide study by the Indian Council of Medical Research-India Diabetes (ICMR-INDIAB), has found that changing dietary habits among Indians are closely associated with rising rates of diabetes and obesity. The survey covered 1,21,077...

FDA’s Approval of Remibrutinib for CSU, With Giselle Mosnaim, MD

The US Food and Drug Administration (FDA) has approved remibrutinib, a selective Bruton’s tyrosine kinase (BTK) inhibitor, for adults with chronic spontaneous urticaria (CSU).1,2 The approval, announced on September 30, 2025, by Novartis, provides...

Discussing Remibrutinib Following FDA Approval for CSU, With Adam Friedman, MD

Following the US Food and Drug Administration (FDA) approval of remibrutinib for adult patients with chronic spontaneous urticaria (CSU), the HCPLive team spoke with Adam Friedman, MD, on the approval and its significance for patients and...

Pfizer’s $70B US Investment Deal with Trump Dodges Tariffs, Cuts Prices

In a move that underscores the Trump administration’s aggressive push to reshape the pharmaceutical industry, Pfizer Inc. has struck a landmark deal to avert steep tariffs while committing to substantial domestic investments and price reductions....

A REFORMIST ENDEAVOUR BY PCI

After a gap of 11 years, the Pharmacy Council of India (PCI) has recently come out with a new draft syllabus for B Pharm course which seeks to produce competent and innovative professionals who can excel in healthcare delivery, industrial...

FDA Approves Remibrutinib for Chronic Spontaneous Urticaria

The US Food and Drug Administration (FDA) approved remibrutinib (Rhapsido), a highly selective Bruton’s tyrosine kinase (BTK) inhibitor, for adults with chronic spontaneous urticaria (CSU).1 Novartis announced the approval on September 30, 2025....

After 50% Tariff, Donald Trump Hits India With 100% Tax on Medicines, Targets Pharma Companies

In a move that could deal a severe blow to India’s booming pharmaceutical sector, Donald Trump has imposed a 100% tariff on medicines imported into the US, demanding pharma giants manufacture locally. India, which supplies over 30% of all generic...

Pfizer shares jump 7% after deal with Trump earns three-year tariff reprieve

Pfizer Inc. secured a reprieve from President Donald Trump’s long-threatened tariffs on the pharmaceutical industry Tuesday by agreeing to slash some of its drug prices by up to 85% and selling directly to the American public, a move other major...

<![CDATA[2025 SCRS Global Site Solutions Summit: Why Collaboration and Feedback Loops Are Essential in Clinical Research]]>

ACT: What have been some of your key takeaways from the event so far? Bechtel: Key takeaways from the event: We've talked a lot about how important communication and collaboration are. We've moved from this era where, “We need to communicate. We...

World pharmacists day: Akwa Ibom ACPN calls for stronger local pharma industry

The Association of Community Pharmacists of Nigeria (ACPN), Akwa Ibom State Branch, has called on governments at all levels to prioritise local pharmaceutical production to tackle the rising cost of medicines and reduce dependence on imports....

COVID vaccines may have averted thousands of hospital stays in infants, pregnant women over 18 months

A US modeling study published yesterday in JAMA Pediatrics estimates that vaccinating pregnant women against COVID-19 prevented 7,000 hospitalizations in infants and 3,000 in pregnant women from January 2024 to May 2025. The Stanford...

Q&A: How Rural Pharmacists Are Stepping Up in Areas of Contraceptive Care

Between a slew of both patient and provider hurdles spurred by state- and federal-level legislation, the delivery and access of contraceptive care in the US have been a challenge as of late. While many issues within women’s health underscore...

Business confidence crashes to record low as bosses demand 'credible plan' to kick-start floundering economy

Business confidence has plunged to a record low as tax fears stifle sentiment and hold back growth, a damning new poll has revealed. The Chancellor was urged to come up with a ‘more coherent and credible plan’ for the economy after the findings by...

Key pediatric FDA decisions to watch for in Q4 2025

The fourth quarter of 2025 has all but arrived, and with it, several key potential approvals from the FDA for the pediatric population. From treatments for achondroplasia, to atopic dermatitis (AD) in children 2 to 5 years, these potential FDA...

AI Just Hacked the $2 Trillion Pharma Industry

The drug discovery rat race is being quietly upended — and few outside the lab are watching. Back in 2020, for the first time in history, a pill designed entirely by artificial intelligence entered human trials. Most people didn’t realize it, and...